TXMD

TherapeuticsMD, Inc. TXMD

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TXMD PRPH AYTU BFRI PHGE GELS EKSO ERNA MPLT AMS
6M 42.86 % -82.38 % 17.67 % 15.33 % -78.02 % -54.69 % 73.65 % -32.45 % -1.20 % -13.75 %
YTD 8.28 % -93.01 % 48.82 % -33.94 % -86.60 % -63.45 % -41.43 % -77.08 % -1.20 % -33.87 %
1Y 55.96 % -90.18 % 65.36 % -32.71 % -83.53 % -64.63 % -41.31 % -70.12 % -1.20 % -32.57 %
3Y -67.56 % -98.71 % -33.42 % -95.76 % -93.88 % -70.41 % -68.83 % -97.34 % -1.20 % -24.92 %
5Y -97.21 % -98.88 % -97.96 % -99.18 % -99.82 % -70.41 % -94.47 % -99.91 % -1.20 % -3.27 %
10Y -99.69 % -98.00 % -100.00 % -99.18 % -99.89 % -70.41 % -99.68 % -99.97 % -1.20 % 29.38 %
From the beginning -99.96 % -75.40 % -100.00 % -99.18 % -99.89 % -70.41 % -99.85 % -100.00 % -1.20 % -64.00 %

Dividend

ProPhase Labs, Inc.

American Shared Hospital Services